Immuno-Biological Laboratories Co., Ltd. (4570.T)
JPY 474.0
(-0.84%)
JPY 474.0
(-0.84%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 816.7 Million JPY | 2.78% |
| 2022 | 794.62 Million JPY | 22.71% |
| 2021 | 647.57 Million JPY | 7.44% |
| 2020 | 602.74 Million JPY | 4.64% |
| 2019 | 576 Million JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 229 Million JPY | -14.65% |
| 2023 Q3 | 182.88 Million JPY | -2.89% |
| 2023 Q1 | 177.18 Million JPY | -26.08% |
| 2023 Q4 | 268.29 Million JPY | 46.7% |
| 2023 FY | 816.7 Million JPY | 2.78% |
| 2023 Q2 | 188.32 Million JPY | 6.29% |
| 2022 Q3 | 261.74 Million JPY | 91.46% |
| 2022 FY | 794.62 Million JPY | 22.71% |
| 2022 Q4 | 239.71 Million JPY | -8.42% |
| 2022 Q2 | 136.71 Million JPY | 0.0% |
| 2021 FY | 647.57 Million JPY | 7.44% |
| 2020 FY | 602.74 Million JPY | 4.64% |
| 2019 FY | 576 Million JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | 82.879% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -623.218% |
| GNI Group Ltd. | 26.01 Billion JPY | 96.86% |
| Linical Co., Ltd. | 12.3 Billion JPY | 93.364% |
| Trans Genic Inc. | 13.08 Billion JPY | 93.758% |
| MEDINET Co., Ltd. | 661.54 Million JPY | -23.454% |
| Soiken Holdings Inc. | 5.15 Billion JPY | 84.168% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | 47.66% |
| AnGes, Inc. | 152.98 Million JPY | -433.844% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | -33.86% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 93.603% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | -502.696% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | 49.769% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | -90.656% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | 57.043% |
| Chiome Bioscience Inc. | 682.46 Million JPY | -19.669% |
| Kidswell Bio Corporation | 2.43 Billion JPY | 66.408% |
| PeptiDream Inc. | 28.71 Billion JPY | 97.156% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -1195.569% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | 121 Million JPY | -574.96% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -1134206.944% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -1947.537% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | 81.894% |
| FunPep Company Limited | 530 Thousand JPY | -153994.528% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -1079.352% |
| Stella Pharma Corporation | 269.49 Million JPY | -203.053% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | -157.782% |
| Cuorips Inc. | 23.1 Million JPY | -3435.196% |
| K Pharma,Inc. | 1 Billion JPY | 18.33% |
| Takara Bio Inc. | 43.5 Billion JPY | 98.123% |
| ReproCELL Incorporated | 2.42 Billion JPY | 66.347% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | 52.388% |
| StemCell Institute Inc. | 2.48 Billion JPY | 67.084% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | 67.516% |
| CellSeed Inc. | 190.13 Million JPY | -329.54% |